ORAtel is a software application to assign percent risk of opioid-induced respiratory depression based on a validated multivariate linear regression model coupled with drug interactions.  This app also assesses the risk of opioid abuse and misuse. This app was sponsored by Daiichi Sankyo.

Assign percent risk of opioid-induced respiratory depression based on a validated multivariate linear regression model coupled with drug interactions

Assess risk of opioid abuse and misuse

Generate personalized chart note to save as PDF or copy/paste into the chart

Personalized PDF chart note

Supportive Literature

  1. Zedler BK, Saunders WB, Joyce AR, Vick CC, Murrelle EL. Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US commercial health plan claims database. Pain Medicine. 2017 Mar 6;19(1):68-78.
  2. Zedler BK, Saunders W, Joyce A, Vick C, Murrelle L. Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a national commercial insurance claims database. Pain Medicine, 2015.
  3. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool. Pain Medicine. 2005; 6(6): 432-442.